Patient Demographic Features for the Study Cohorts
| Demographics | Bile gastropathy (n = 90) |
Non-bile gastropathy (n = 121) |
No gastropathy (n = 51) |
|
|---|---|---|---|---|
| Age (yr) | 49.3 ± 16 | 49.7 ± 16.0 | 51.0 ± 16.0 | 0.823 |
| Female | 85.6% | 71.9% | 76.5% | 0.062 |
| Body mass index (kg/m2) | 28.2 ± 9.0 | 26.6 ± 8.0 | 25.8 ± 5.0 | 0.145 |
| Diabetes mellitus | 16.7% | 14.1% | 15.7% | 0.869 |
| Hemoglobin A1C (%) | 8.0 ± 2.0 | 7.6 ± 1.6 | 8.2 ± 1.9 | 0.804 |
| Histamine H2 receptor antagonists use | 5.6% | 6.6% | 7.8% | 0.867 |
| Proton pump inhibitors use | 58.9% | 54.5% | 56.9% | 0.819 |
| Any anti-acid medication use | 64.4% | 61.2% | 64.7% | 0.852 |
| Aspirin use | 14.4% | 12.4% | 13.7% | 0.907 |
| NSAID use | 13.8% | 19.1% | 11.1% | 0.374 |
| Chronic prescription narcotics | 24.4% | 20.7% | 15.7% | 0.468 |
NSAID, non-steroidal anti-inflammatory drug.
Values are presented as mean ± SD.